Courtney Crim Selected Research

fluticasone furoate

1/2021	Effect of Age on Efficacy and Safety of Fluticasone Furoate/Vilanterol (FF/VI), Umeclidinium (UMEC), and UMEC + FF/VI in Patients with Chronic Obstructive Pulmonary Disease: Analyses of Five Randomized Clinical Trials.
1/2021	Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACT.
1/2021	Validation of the Summit Lab Score in Predicting Exacerbations of Chronic Obstructive Pulmonary Disease Among Individuals with High Arterial Stiffness.
5/2020	A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD.
1/2020	Effect of once-daily fluticasone furoate/vilanterol versus vilanterol alone on bone mineral density in patients with COPD: a randomized, controlled trial.
1/2020	Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.
6/2019	Treatment Patterns of New Users of Fluticasone Furoate/Vilanterol in Asthma and COPD in UK Primary Care: Retrospective Cohort Study.
2/2019	Impact of pre-enrolment medication use on clinical outcomes in SUMMIT.
1/2018	β-Blocker Therapy and Clinical Outcomes in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. An Observational Substudy of SUMMIT.
1/2018	Predictors of pneumonia on routine chest radiographs in patients with COPD: a post hoc analysis of two 1-year randomized controlled trials.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Courtney Crim Research Topics

Disease

59	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 11/2006
14	Asthma (Bronchial Asthma) 06/2019 - 10/2002
9	Pneumonia (Pneumonitis) 12/2021 - 05/2013
7	Emphysema 01/2021 - 09/2011
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 01/2016
2	Inflammation (Inflammations) 01/2021 - 05/2012
2	Myocardial Infarction 01/2020 - 10/2017
1	Gastroenteritis 05/2020
1	Vomiting 05/2020
1	Heart Failure 01/2020
1	Stroke (Strokes) 10/2017
1	Unstable Angina 10/2017
1	Heart Diseases (Heart Disease) 09/2013
1	Dyspnea (Shortness of Breath) 12/2012

Drug/Important Bio-Agent (IBA)

30	vilanterolIBA 01/2021 - 07/2012
29	fluticasone furoate FDA Link 01/2021 - 08/2012
24	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 10/2002
13	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2012
8	Bronchodilator Agents (Bronchodilators)IBA 01/2022 - 12/2005
7	Fluticasone (Cutivate)FDA LinkGeneric 11/2006 - 10/2002
6	Albuterol (Salbutamol)FDA LinkGeneric 08/2012 - 08/2005
4	GSK573719IBA 01/2021 - 01/2019
4	GoldIBA 09/2013 - 07/2011
3	Pharmaceutical PreparationsIBA 05/2020 - 08/2012
3	Fibrinogen (Factor I)FDA Link 01/2019 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2014
3	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2016 - 06/2006
3	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 08/2014 - 12/2004
3	Salmeterol Xinafoate (Serevent)FDA Link 08/2010 - 12/2004
3	apaflurane (hydrofluoroalkane)IBA 11/2006 - 01/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2017
2	batefenterolIBA 05/2020 - 01/2019
2	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2019 - 08/2014
2	Interleukin-8 (Interleukin 8)IBA 08/2014 - 09/2013
2	AerosolsIBA 11/2006 - 01/2006
2	montelukast (Singulair)FDA Link 08/2005 - 12/2004
1	CytokinesIBA 01/2021
1	XanthinesIBA 01/2020
1	Anti-Arrhythmia AgentsIBA 01/2020
1	SteroidsIBA 06/2019
1	GlycogenIBA 01/2019
1	C-Reactive ProteinIBA 01/2019
1	Muscarinic AntagonistsIBA 01/2019
1	Troponin IIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	ORALIT (ORS)IBA 01/2018
1	CI 22IBA 01/2017
1	Tiotropium Bromide (Spiriva)FDA Link 01/2016
1	InterleukinsIBA 08/2014
1	CalciumIBA 08/2014
1	fluticasone furoate-vilanterol trifenatateIBA 03/2014
1	Interleukin-6 (Interleukin 6)IBA 09/2013
1	nasIBA 02/2012
1	GlucocorticoidsIBA 06/2006
1	norflurane (R 134a)IBA 12/2005
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 12/2004

Therapy/Procedure

16	Therapeutics 01/2021 - 12/2004
3	Nebulizers and Vaporizers (Inhaler) 01/2021 - 01/2020
2	Dry Powder Inhalers 01/2019 - 08/2012
2	Metered Dose Inhalers (Metered Dose Inhaler) 06/2006 - 12/2005
1	Drug Therapy (Chemotherapy) 01/2021
1	Off-Label Use 06/2019